Home > Boards > US Listed > Medical - Drugs > Mallinckrodt PLC (MNK)

$MNK bulls and bears https://news.squeezereport.com/short-squeeze/mallinckrodt-plc-nyse-

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
whytestocks Member Profile
Member Level 
Followed By 55
Posts 7,004
Boards Moderated 1
Alias Born 06/04/18
160x600 placeholder
Mallinckrodt Presents Data on a Novel Predictive Model to Identify Infants at Risk for Infantile Spasms (IS) at the 2019 Annu... PR Newswire (US) - 12/7/2019 12:05:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/5/2019 6:49:48 AM
Mallinckrodt plc Announces Final Results of Exchange Transactions PR Newswire (US) - 12/5/2019 6:45:00 AM
Mallinckrodt Moves Date and Time of Its Fireside Chat at Piper Jaffray Annual Healthcare Conference PR Newswire (US) - 12/2/2019 7:20:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/27/2019 6:46:25 AM
Opioid Makers Hit With Criminal Probe -- WSJ Dow Jones News - 11/27/2019 3:02:00 AM
Opioid Makers, Distributors Fall Following WSJ Report on Federal Probe Dow Jones News - 11/26/2019 1:51:00 PM
Federal Prosecutors Launch Criminal Probe of Opioid Makers, Distributors Dow Jones News - 11/26/2019 1:18:00 PM
Data on Acthar® Gel (Repository Corticotropin Injection) Therapy in Symptomatic Sarcoidosis Published in Therapeutic Advance... PR Newswire (US) - 11/26/2019 6:45:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/20/2019 6:37:41 AM
Mallinckrodt plc Announces Early Results of Exchange Transactions PR Newswire (US) - 11/19/2019 8:38:00 PM
Mallinckrodt to Present at Piper Jaffray Annual Healthcare Conference PR Newswire (US) - 11/19/2019 6:45:00 AM
Mallinckrodt Announces New Clinical Data Evaluating Acthar® Gel (Repository Corticotropin Injection) in Rheumatoid Arthritis... PR Newswire (US) - 11/12/2019 4:30:00 PM
Mallinckrodt Presents Positive Phase 3 Results from its CONFIRM Study of Terlipressin in Patients with Hepatorenal Syndrome T... PR Newswire (US) - 11/11/2019 3:30:00 PM
Mallinckrodt to Present at Jefferies London Healthcare Conference PR Newswire (US) - 11/8/2019 6:45:00 AM
Mallinckrodt to Present at Jefferies London Healthcare Conference PR Newswire (US) - 11/8/2019 6:45:00 AM
Mallinckrodt Announces Data Publication on the Treatment Effectiveness of Acthar® Gel (Repository Corticotropin Injection) f... PR Newswire (US) - 11/7/2019 6:45:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/5/2019 5:01:37 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/5/2019 6:10:32 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/5/2019 6:10:21 AM
Mallinckrodt plc Announces Exchange Offers and Consent Solicitations PR Newswire (US) - 11/5/2019 6:05:00 AM
Mallinckrodt plc Reports Earnings and Pipeline Advancements for the Third Quarter 2019 and Raises Adjusted Diluted Earnings P... PR Newswire (US) - 11/5/2019 6:00:00 AM
Mallinckrodt Completes Sale of BioVectra Inc. for up to $250 Million PR Newswire (US) - 11/4/2019 4:30:00 PM
Mallinckrodt Announces UVADEX® (Methoxsalen) Approved in Australia for use with the THERAKOS® CELLEX® Photopheresis System... PR Newswire (US) - 10/31/2019 4:35:00 PM
Mallinckrodt Announces UVADEX® (Methoxsalen) Approved in Australia for use with the THERAKOS® CELLEX® Photopheresis System... PR Newswire (US) - 10/31/2019 4:35:00 PM
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist